Skip to main content
. 2016 Dec 20;34(2):495–512. doi: 10.1007/s12325-016-0464-9

Fig. 3.

Fig. 3

Unadjusted Kaplan–Meier OS curves for dacarbazine and gp100 vs observed OS curve for GM-CSF, all patients (stage IIIB–IV M1c). GM-CSF granulocyte-macrophage colony-stimulating factor, gp100 glycoprotein 100, OS overall survival